The Total Revenue is greatly enhance from a merely $185m in 2013 to $908.7m. A vast improvement of having a CAGR of 97% for past 4 years. A splendid achievement indeed!
The EPS was growing at a CAGR of 31.16%, a high double digits grow rate which is pretty impressive . Diluted EPS for 2013 was 1.4 cents versus EPS of 4.2 cents in 2017.
Total Net Income has also been growing and increasing at a higher magnitude from $29.5m in 2013 to $115.9m in 2017. A vast improvement of 3.9 times or 390% increased of its Net Income value.
Superb achievement!
Dividend paying out has been greatly increased from 0.3 cents in 2013 to 1.5 cents in 2017. Giving a yield of 2.1%.
EBITDA has been greatly increasing from $47.65m in 2013 to $229.13m in 2017. A 480% improvement from 2013 to 2017. The company is growing its revenue at a fantastic enhancement rate.
The total Assets has also been increasing from $567.1m of 2013 to $$3608.7m in 2017.
The company has been growing its total Assets at a greater magnitude 6.3 times.
Ops cash flow has been pretty healthy as reflected on the table below.
Investor may want to take note of the super high of Total Debts to Equity ratio of 43.98%.
I have roughly workout the EPS DCF Intrinsic value for this counter using a CAGR of 31.16%, discount factor of 15% of which the fair value is 95 cents.
If I want to factor in a greater Margin of Safety , i may increase the discount factor to 18% that would still give me a fair value of 81 cents.
The current price of 70 cents , at PE 22 times , Rolling PE at 16 times seems trading below its fair value. The potential of 15.6% if Target price is based on 81 cents and 35.6% if Target price is being set at 95 cents.
NAV of 41.4 cents. P/B 1.8 times.
From TA point of view, after hitting the high of 85.2 cents in 29 Mar 2017, it has since retreated sharply and continue to slide down further to close at 70 cents as of last Fri - 13 April 2018.
It is now stuck in a consolidated mode patterns . It can go either way. Which means to say it may continue to slide further down or bounce-off from here and move up the channel.
Not a call to buy or sell.
Please do your own due diligence.
Trade/Invest base on your own decision.
CITIC Envirotech Ltd. Announces Placement of New Shares to New Resources LLC Raising Approximately SGD 70.7 Million in Gross Proceeds (PROPOSED PLACEMENT OF 83,216,080 NEW ORDINARY SHARES )
The Placement Price of S$0.85 is at a premium of 14.8% to the weighted average price of S$0.7407 for trades done on the ordinary shares in the capital of CEL (“Shares”) on the Singapore Exchange Securities Trading Limited (“SGX-ST”) on 27 December 2017, being the last full market day on which the Shares were traded prior to the date the Placement Agreement
CITIC Envirotech Ltd. provides integrated water solutions in the People’s Republic of China, the United States, and Malaysia. It operates through Engineering, Treatment, and Membrane segments.
The company involved in the design, fabrication, installation, and commissioning of membrane-based water and wastewater treatment systems, as well as in undertaking various turnkey projects in the capacity of engineering, procurement, and construction contractor or as a membrane system specialist. It also invests in wastewater treatment projects under transfer-operate-transfer and build-own-transfer arrangements; and operates and manages third party treatment facilities.
In addition, the company manufactures and supplies polyvinylidene fluoride hollow fiber membrane, and pressurized and submerged membrane products and integrated membrane systems; and trades in pumps. It serves the chemical, petrochemical, and municipal and industrial park sectors. The company was formerly known as United Envirotech Ltd. and changed its name to CITIC Envirotech Ltd. in July 2015. The company was founded in 1996 and is based in Singapore. CITIC Envirotech Ltd. is a subsidiary of CITIC Limited.
No comments:
Post a Comment